Compare Edwards Lifesciences Corporation Common Stock (EW) vs Nu Holdings Ltd (NU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edwards Lifesciences Corporation Common Stock vs Nu Holdings Ltd — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $84.24 (market cap $48.56B), while Nu Holdings Ltd trades at $15.57 (market cap $74.30B). The key difference: Nu Holdings Ltd is the larger of the two by market cap, and Nu Holdings Ltd is more actively traded (80,294,805 versus 6,520,488). Which is the better fit depends on your goals.
| EW | NU | |
|---|---|---|
Market Cap | $48.56B | $74.30B |
Volume | 6,520,488 | 80,294,805 |
Sector | Health | Financials |
52-Week High | $95.18 | $18.76 |
52-Week Low | $72.65 | $11.60 |
Enterprise Value | $45.01B | $96.91B |
Typical Hold Time | — | 53 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
NU Holdings (NU) trades at $15.58, down 0.51% on the day, with strong fundamental momentum despite recent volatility. The stock shows bullish technical signals with moving averages supporting upward trends, while oscillators indicate some near-term pressure. Revenue growth has accelerated from $3.0B in 2022 to $10.6B in 2025, with net income turning positive and reaching $2.9B. Recent news highlights acquisition speculation and Goldman Sachs' bullish stance, though the company denied Monzo deal talks.
The outlook remains positive with 56.5% analyst buy ratings and a $16.53 consensus target offering 6% upside. Key opportunities include expanding Latin American digital banking penetration and strong profitability metrics (27.4% net margin). Risks include credit quality concerns from rising delinquencies and competitive pressures in fintech. The stock presents a growth opportunity but requires monitoring of execution risks and market sentiment shifts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →About Nu Holdings Ltd
Nu Holdings Ltd is engaged in providing digital banking services. It offers several financial services such as Credit cards, Personal Account, Investments, Personal Loans, Insurance, Mobile payments, Business Account, and Rewards.
Read more on NU →
